Lucid Diagnostics (LUCD) Total Current Liabilities (2021 - 2026)

Lucid Diagnostics' Total Current Liabilities history runs 6 years deep, the most recent figure standing at $29.4 million for Q1 2026.

• Quarterly Total Current Liabilities fell 19.65% year-over-year to $29.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.4 million (down 19.65% YoY) and the FY2025 annual result came in at $28.6 million, up 21.5% from the prior year.
• Total Current Liabilities was $29.4 million for Q1 2026 at Lucid Diagnostics, up from $28.6 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $36.6 million in Q1 2025 and bottomed at $7.9 million in Q2 2022.
• A 5-year average of $22.0 million and a median of $23.5 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities soared 248.75% — and 2024, when it plunged 52.86%.
• Lucid Diagnostics' Total Current Liabilities stood at $8.4 million in 2022, then surged by 248.75% to $29.4 million in 2023, then declined by 19.94% to $23.5 million in 2024, then advanced by 21.5% to $28.6 million in 2025, then increased by 2.81% to $29.4 million in 2026.
• Business Quant data shows LUCD's Total Current Liabilities at $29.4 million in Q1 2026, $28.6 million in Q4 2025, and $26.2 million in Q3 2025.